Cancer
-
Sanjiv Sam Gambhir dies at 57
The professor and chair of radiology at Stanford was a global leader in advancing techniques for molecular imaging and early cancer detection.
-
Cancer experience drives scientific curiosity
New Stanford graduate Nico Poux, a former pediatric oncology patient at Lucile Packard Children’s Hospital Stanford, hopes to bring his experience with cancer to future work as a physician-scientist.
-
Subset of cells drive cancer growth
Specialized cells at the leading edge of growing skin cancers dampen immune response and promote cancer invasion, Stanford researchers find. Targeting these cells could lead to effective therapies.
-
Stanford Medicine magazine: Cracking cancer’s code
A special report on cancer in Stanford Medicine magazine looks at innovations in cancer treatment, research and education.
-
Young adults don’t know what’s in vape products
Nicotine pods used for vaping need clearer labels to help young people understand what they are inhaling, a Stanford study concludes.
-
Cancer-associated mutations relatively common
Postmenopausal women with breast cancer are as likely as Ashkenazi Jewish women to carry inherited breast-cancer mutations that can inform treatment, a Stanford study found.
-
Industry-linked studies favorable to indoor tanning
Indoor-tanning studies with financial ties to the industry are likely to downplay risks and discuss the potential benefits of tanning, researchers have found.
-
Single number IDs deadly cancer cells
Stanford data scientists have shown that figuring out a single number can help them find the most dangerous cancer cells.
-
From antiviral to possible cancer drug
An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice.
-
NCI director says cancer research booming
In a speech at Stanford, National Cancer Institute Director Norman Sharpless reported promising cancer mortality trends and described an encouraging landscape for research funding and drug approval.
-
Next generation of CAR-T cells possible
CAR-T cells are remarkably effective against blood cancers, but their effect can be transient as the cells become exhausted. Stanford researchers found a way to keep the cells effective in mice with human tumors.
- Administration
- Aging
- Big Data
- Biochemistry
- Bioengineering
- Cancer
- Cardiovascular Health
- Chemical Biology
- Chronic Disease
- COVID-19
- Developmental Biology
- Education
- Genetics
- Global Health
- Health Policy
- Hearing
- Imaging
- Immunology
- Infectious Disease
- Mental Health
- Neuroscience
- Nutrition
- Obituaries
- Pain
- Patient Care
- Pediatrics
- Precision Health
- Preventive Medicine
- Sleep
- Stem Cells
- Surgery
- Technology
- Transplantation
- Urology
- Women's Health